No connection

Search Results

IH

NEUTRAL
$1.74 Live
iHuman Inc. · NYSE
$1.55 52W Range $3.6

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026
Market cap
$88.94M
P/E
6.69
ROE
9.8%
Profit margin
11.8%
Debt/Equity
0.01
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
iHuman Inc. presents a classic deep-value paradox: it possesses a stable Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. While the stock trades at a significant discount to its Graham Number ($4.08) and book value (P/B 0.61), the negative YoY revenue (-18.10%) and earnings (-33.30%) growth suggest a value trap. The current price of $1.74 is slightly below the growth-based intrinsic value of $1.82, but the bearish technical trend and weak insider sentiment offset the valuation appeal.

Key Strengths

Extremely low valuation multiples (P/E 6.69, P/S 0.11)
Strong liquidity position with a Current Ratio of 3.57
Negligible leverage with a Debt/Equity ratio of 0.01
Trading significantly below book value (P/B 0.61)
Stable financial health as indicated by a Piotroski F-Score of 6/9

Key Risks

Significant revenue contraction (-18.10% YoY)
Sharp decline in earnings growth (-33.30% YoY)
Strongly bearish technical trend (0/100)
Micro-cap volatility and low market capitalization ($0.09B)
Weak insider sentiment (40/100) suggesting lack of internal confidence
AI Fair Value Estimate
Based on comprehensive analysis
$2.15
+23.6% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
43
Moderate
Value
95
Future
20
Past
15
Health
85
Dividend
0
AI Verdict
Value Trap Risk
Key drivers: Deep valuation discount, Negative growth trajectory, Strong balance sheet
Confidence
90%
Value
95/100

Ref P/E 6.69, P/B 0.61, Graham Number $4.08

Positives
  • P/E far below sector average
  • P/B below 1.0
  • Price well below Graham Number
Watchpoints
  • Low price reflects fundamental decay
Future
20/100

Ref Revenue Growth -18.10%, Earnings Growth -33.30%

Positives
  • Positive profit margins
Watchpoints
  • Negative YoY Revenue Growth
  • Negative Q/Q Earnings Growth
Past
15/100

Ref Historical Price Performance

Positives
  • Recent 1-month recovery (+9.7%)
Watchpoints
  • 5Y Change of -84.7%
  • Consistent downward trend over 1Y and 6M
Health
85/100

Ref Piotroski F-Score, Debt/Equity 0.01

Positives
  • Piotroski F-Score 6/9
  • Very low Debt/Equity
  • High Quick Ratio
Watchpoints
  • Altman Z-Score not provided
Dividend
0/100

Ref Dividend Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.74

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for IH and closest competitors.

Updated 2026-04-28
IH
iHuman Inc.
Primary
5Y
-84.7%
3Y
-35.1%
1Y
-10.5%
6M
-30.4%
1M
+9.7%
1W
+1.2%
SLS
Solesence, Inc.
Peer
5Y
-21.9%
3Y
-0.8%
1Y
-44.2%
6M
-67.3%
1M
+54.3%
1W
+12.6%
SOW
Sow Good Inc.
Peer
5Y
-95.2%
3Y
-92.5%
1Y
-50.0%
6M
-59.5%
1M
-31.8%
1W
-21.1%
DIT
AMCON Distributing Company
Peer
5Y
+1.4%
3Y
-26.9%
1Y
+14.4%
6M
+14.3%
1M
+0.8%
1W
-7.7%
FTL
FitLife Brands, Inc.
Peer
5Y
+146.8%
3Y
+17.9%
1Y
-17.9%
6M
-51.6%
1M
-32.4%
1W
-7.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
6.69
Forward P/E
9.16
PEG Ratio
N/A
P/B Ratio
0.61
P/S Ratio
0.11
EV/Revenue
-0.86
EV/EBITDA
-8.64
Market Cap
$88.94M

Profitability

Profit margins and return metrics

Profit Margin 11.82%
Operating Margin 4.72%
Gross Margin 67.86%
ROE 9.75%
ROA 2.99%

Growth

Revenue and earnings growth rates

Revenue Growth -18.1%
Earnings Growth -33.3%
Q/Q Revenue Growth -18.06%
Q/Q Earnings Growth -41.8%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.01
Low debt
Current Ratio
3.57
Strong
Quick Ratio
3.3
Excellent
Cash/Share
$4.5

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.2B
Gross Margin
66.9%
Op. Margin
4.7%
Net Margin
8.1%
Total Assets
$1.4B
Liabilities
$0.4B
Equity
$1.0B
Debt/Equity
0.37x

Consumer Defensive Sector Comparison

Comparing IH against 172 companies in the Consumer Defensive sector (9 bullish, 62 neutral, 101 bearish)
P/E Ratio
6.69
This Stock
vs
36.88
Sector Avg
-81.9% (Discount)
Return on Equity (ROE)
9.75%
This Stock
vs
-13.57%
Sector Avg
-171.9% (Below Avg)
Profit Margin
11.82%
This Stock
vs
-7.55%
Sector Avg
-256.5% (Weaker)
Debt to Equity
0.01
This Stock
vs
1.86
Sector Avg
-99.4% (Less Debt)
Revenue Growth
-18.1%
This Stock
vs
110.28%
Sector Avg
-116.4% (Slower)
Current Ratio
3.57
This Stock
vs
2.3
Sector Avg
+55.0% (Stronger)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2026-04-24
20-F
20-F
2025-04-28
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning IH from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile